6TL1

Crystal structure of the TASOR pseudo-PARP domain

Summary for 6TL1

• Entry DOI: 10.2210/pdb6tl1/pdb
• Descriptor: Protein TASOR, GLYCEROL (3 entities in total)
• Functional Keywords: nuclear protein; transcriptional repressor; epigenetic silencing; histone h3 lysine 9 methylation (h3k9me3); transposable element; line1 element; rna-binding protein, gene regulation
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 2
• Total formula weight: 49736.95

Authors

Douse, C.H.,Timms, R.T.,Freund, S.M.V.,Modis, Y. (deposition date: 2019-11-29, release date: 2020-09-16, Last modification date: 2024-05-15)

Primary citation

Douse, C.H.,Tchasovnikarova, I.A.,Timms, R.T.,Protasio, A.V.,Seczynska, M.,Prigozhin, D.M.,Albecka, A.,Wagstaff, J.,Williamson, J.C.,Freund, S.M.V.,Lehner, P.J.,Modis, Y.
TASOR is a pseudo-PARP that directs HUSH complex assembly and epigenetic transposon control.
Nat Commun, 11:4940-4940, 2020

PubMed Abstract: The HUSH complex represses retroviruses, transposons and genes to maintain the integrity of vertebrate genomes. HUSH regulates deposition of the epigenetic mark H3K9me3, but how its three core subunits - TASOR, MPP8 and Periphilin - contribute to assembly and targeting of the complex remains unknown. Here, we define the biochemical basis of HUSH assembly and find that its modular architecture resembles the yeast RNA-induced transcriptional silencing complex. TASOR, the central HUSH subunit, associates with RNA processing components. TASOR is required for H3K9me3 deposition over LINE-1 repeats and repetitive exons in transcribed genes. In the context of previous studies, this suggests that an RNA intermediate is important for HUSH activity. We dissect the TASOR and MPP8 domains necessary for transgene repression. Structure-function analyses reveal TASOR bears a catalytically-inactive PARP domain necessary for targeted H3K9me3 deposition. We conclude that TASOR is a multifunctional pseudo-PARP that directs HUSH assembly and epigenetic regulation of repetitive genomic targets.

PubMed: 33009411
DOI: 10.1038/s41467-020-18761-6

Experimental method

X-RAY DIFFRACTION (2.03 Å)